PBM (PBM) Stock Price & Analysis
PBM (PBM) rose 2.48% to USD 4.54 as of September 8, 2026 at 12:44 UTC, according to Nexqual real-time market data.
PBM last closed at USD 4.54; the session ranged USD 4.33–4.71 on volume of 27,766 shares. Market capitalization is —, with a 52-week range of USD 1.92–216.41 (NCM). Source: Nexqual, September 8, 2026 at 12:44 UTC.
Key Statistics (as of September 8, 2026 at 12:44 UTC)
| Price | USD 4.54 |
|---|---|
| Change | ▲ 2.48% (up) |
| Previous Close | USD 4.54 |
| Open | USD 4.54 |
| Day Range | USD 4.33 – 4.71 |
| 52-Week Range | USD 1.92 – 216.41 |
| Volume | 27,766 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (PBM)
Nexqual's technical model rates PBM "STRONG BUY" based on 5 bullish and 0 bearish signals across 128 daily candles, as of September 8, 2026 at 12:44 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 67.59 (neutral) |
| vs SMA50 | Above (USD 3.47) |
| MACD | 0.29 (positive) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| RENX | RenX Enterprises Corp. | USD 1.96 | ▼ 8.41% |
| MIRA | MIRA Pharmaceuticals, Inc. | USD 0.76 | ▼ 10.12% |
| CMND | Clearmind Medicine Inc. | USD 1.16 | ▼ 37.3% |
| GXAI | Gaxos.ai Inc. | USD 0.76 | ▲ 0% |
| CERO | CERo Therapeutics Holdings, Inc | USD 0.01 | ▼ 31.25% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 12:44 UTC. This page is informational and not investment advice.